Company news

Plus Therapeutics, Inc. news in 2021

Plus Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Plus Therapeutics Announces Positive Interim Data from ReSPECT™-GBM Phase 1 Clinical Trial at the 2021 Society for Neuro-Oncology Annual Meeting

November 17, 2021

Plus Therapeutics Receives FDA Fast Track Designation for 186RNL Targeted Radiotherapeutic for Leptomeningeal Metastases

November 8, 2021

Plus Therapeutics Announces Presentation of ReSPECT-GBM Trial Dosimetery Data at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting

October 26, 2021

Plus Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights

October 20, 2021

Plus Therapeutics Announces FDA Clearance of Investigational New Drug Application for 186RNL for the Treatment of Leptomeningeal Metastases

October 18, 2021

Plus Therapeutics to Announce Third Quarter 2021 Financial Results and Host Conference Call on October 21, 2021

October 13, 2021

Plus Therapeutics Announces the Appointment of Industry Veteran, Norman LaFrance, M.D., as the Company’s Chief Medical Officer

September 12, 2021

Plus Therapeutics Announces Commercial Manufacturing Supply Agreement for Its Lead Investigational Drug

September 1, 2021

Plus Therapeutics Announces Presentation of Data from the ReSPECT™-GBM Trial and Plans for Treating Pediatric Brain Cancer

August 20, 2021

Plus Strengthens Commercial RNL Supply Chain with Ten Year Exclusivity Agreement

July 26, 2021

Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights

July 21, 2021

Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial

June 15, 2021

Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements

May 3, 2021

Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights

April 21, 2021

Plus Therapeutics Enters Into Master Services Agreement with Piramal Pharma Solutions, a Leading Contract Development and Manufacturing Organization

March 22, 2021

Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights

February 21, 2021

Plus Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 22, 2021

February 10, 2021

Calls in 2021